David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATHN
1626
CALL
DELISTED
Athenahealth, Inc.
ATHN
| $2.78M | 0.01% |
20,000
+16,700
| +506% | +$2.29M |
|
1627
Littelfuse
LFUS
$10.6B
| $2.77M | 0.01% |
22,529
+6,685
| +42% | +$737K |
|
1628
PUT
Kohl's
KSS
$2.03B
| $2.77M | 0.01% |
59,400
-15,700
| -21% | -$737K |
|
|
SYKE
1629
DELISTED
SYKES Enterprises Inc
SYKE
| $2.77M | 0.01% |
91,660
-40,510
| -31% | -$1.18M |
|
|
ONE
1630
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
| $2.77M | 0.01% |
707,282
+136,910
| +24% | +$509K |
|
1631
PUT
Hershey
HSY
$37.2B
| $2.76M | 0.01% |
30,000
-52,200
| -64% | -$4.66M |
|
1632
PUT
CVS Health
CVS
$121B
| $2.76M | 0.01% |
26,600
-296,200
| -92% | -$28.8M |
|
1633
Brown & Brown
BRO
$24.4B
| $2.76M | ﹤0.01% |
153,992
-276,334
| -64% | -$4.44M |
|
1634
Clearwater Paper
CLW
$344M
| $2.75M | ﹤0.01% |
56,719
-15,804
| -22% | -$659K |
|
1635
Materion
MTRN
$4.92B
| $2.73M | ﹤0.01% |
103,177
+6,254
| +6% | +$156K |
|
1636
Chefs' Warehouse
CHEF
$4.57B
| $2.72M | ﹤0.01% |
134,089
+48,909
| +57% | +$806K |
|
1637
Banco Bradesco
BBD
$35.5B
| $2.72M | ﹤0.01% |
776,005
+563,024
| +264% | +$1.47M |
|
1638
HealthStream
HSTM
$841M
| $2.72M | ﹤0.01% |
122,971
+41,312
| +51% | +$850K |
|
1639
Capital One
COF
$133B
| $2.71M | ﹤0.01% |
39,163
-292,953
| -88% | -$19.4M |
|
|
OTIC
1640
DELISTED
Otonomy, Inc.
OTIC
| $2.71M | ﹤0.01% |
181,832
+70,117
| +63% | +$1.1M |
|
1641
CALL
CNX Resources
CNX
$5.33B
| $2.71M | ﹤0.01% |
288,000
-30,000
| -9% | -$218K |
|
|
VCRA
1642
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $2.71M | ﹤0.01% |
212,534
-74,177
| -26% | -$1.03M |
|
|
RTEC
1643
DELISTED
Rudolph Technologies Inc
RTEC
| $2.71M | ﹤0.01% |
198,364
-112,932
| -36% | -$1.43M |
|
|
KAMN
1644
DELISTED
Kaman Corp
KAMN
| $2.71M | ﹤0.01% |
63,472
+22,847
| +56% | +$932K |
|
1645
Gogo Inc
GOGO
$386M
| $2.7M | ﹤0.01% |
+244,904
| New | +$3.1M |
|
1646
KB Financial Group
KB
$42.4B
| $2.69M | ﹤0.01% |
97,576
+53,943
| +124% | +$1.38M |
|
1647
PUT
El Pollo Loco
LOCO
$476M
| $2.68M | ﹤0.01% |
201,100
| – | – |
|
1648
Foster
FSTR
$395M
| $2.68M | ﹤0.01% |
147,736
+55,253
| +60% | +$736K |
|
1649
RLJ Lodging Trust
RLJ
$1.75B
| $2.68M | ﹤0.01% |
117,260
+79,917
| +214% | +$1.61M |
|
1650
PUT
Howard Hughes
HHH
$3.92B
| $2.68M | ﹤0.01% |
+26,540
| New | +$2.44M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.